Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo

被引:123
作者
Esmailpour, N
Hogger, P
Rabe, KF
Heitmann, U
Nakashima, M
Rohdewald, P
机构
[1] UNIV MUNSTER, INST PHARMAZEUT CHEM, D-48149 MUNSTER, GERMANY
[2] LVA HAMBURG, KRANKENHAUS GROSSHANSDORF, ZENTRUM PNEUMOL & THORAXCHIRURG, HAMBURG, GERMANY
关键词
fluticasone propionate; glucocorticoid; inhalation; plasma concentration; tissue concentration in vivo;
D O I
10.1183/09031936.97.10071496
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
High retention of inhaled glucocorticoids in the ah-ways means prolonged anti-inflammatory action and low delivery into the serum, The objective of this study was to investigate the retention in and distribution of inhaled fluticasone propionate (FP) between central and peripheral human lung tissue and serum in vivo. In 17 patients undergoing lung resection surgery, a single 1.0 mg dose of FP was inhaled at varying time-points (range 2.8-21.7 h) preoperatively, Peripheral and central lung tissue was obtained, and blood was drawn simultaneously. FP concentrations in central lung tissue were approximately three to four times higher than peripheral lung tissue concentrations, which in turn, exceeded those found in serum by 10 times, FP was detectable up to 21 and 16 h, respectively, after inhalation, with drug levels falling almost in parallel in peripheral lung tissue and in serum. The results of this study demonstrate that fluticasone propionate is retained in lung tissue for a long time. Serum concentrations after a single inhaled dose are low, Retention of high concentrations of fluticasone propionate in the airways may promote high topical anti-inflammatory activity.
引用
收藏
页码:1496 / 1499
页数:4
相关论文
共 11 条
[1]   A SENSITIVE RADIOIMMUNOASSAY, INCORPORATING SOLID-PHASE EXTRACTION, FOR FLUTICASONE 17-PROPIONATE IN PLASMA [J].
BAIN, BM ;
HARRISON, G ;
JENKINS, KD ;
PATEMAN, AJ ;
SHENOY, EVB .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (07) :557-561
[2]   BINDING-KINETICS OF FLUTICASONE PROPIONATE TO THE HUMAN GLUCOCORTICOID RECEPTOR [J].
HOGGER, P ;
ROHDEWALD, P .
STEROIDS, 1994, 59 (10) :597-602
[3]  
HOGGER P, 1994, EUR J PHARM SCI, V2, P159
[4]  
HOGGER P, 1994, EUR RESP J S18, V7, pS382
[5]  
MILLERLARSSON A, 1994, AM J RESP CRIT CARE, V149, pA466
[6]  
PAUWELS R, 1989, PHARM PHARMACOTHERAP, P104
[7]  
ROHDEWALD P, 1995, NEUE ASPEKTE INHALAT, P14
[8]  
RYRFELDT A, 1982, EUR J RESPIR DIS, V63, P86
[9]  
THORSSON L, 1996, EUR RESP J S23, V23, P1645
[10]   RELATIONSHIP BETWEEN LUNG-TISSUE AND BLOOD-PLASMA CONCENTRATIONS OF INHALED BUDESONIDE [J].
VANDENBOSCH, JMM ;
WESTERMANN, CJJ ;
AUMANN, J ;
EDSBACKER, S ;
TONNESSON, M ;
SELROOS, O .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (05) :455-459